Quantcast

Latest Retinitis pigmentosa Stories

187e433136017eff726dd25d732a44ec1
2009-07-08 09:40:00

Scientists use a new technique consisting of the induction of neuronal degeneration for intense light exposure in the mouse's retina, an experimental model of retinitis pigmentosa. Their work is based on the study of microglial cells, practically involved in all the diseases and damages of the nervous system, including Parkinson y Alzheimer.Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light...

2009-06-26 09:44:11

Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, identifying an enzyme that makes neuroprotectin D1 which specifically and selectively protects retinal cells key for vision, will be published in the June 26, 2009 issue of the Journal of Biological Chemistry.Dr. Bazan's research team previously discovered neuroprotectin D1 (NPD1), a naturally produced chemical messenger that protects cells from...

2009-06-11 15:39:26

Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials. Two important early potential hESC applications are the use of RPE for the treatment of age-related macular degeneration and Stargardt disease, an untreatable form of eye disease that leads to early-onset blindness. The...

2009-06-10 09:35:00

Walkers Raised $3000 to Help Fund Sight-Saving Research Through Foundation Fighting Blindness DALLAS, June 10 /PRNewswire/ -- Principal Management Group of North Texas (PMG), an Associa Company, recently participated in a walk-a-thon as "Bonnie Believers" in support of the Greater DFW Chapter of the Foundation Fighting Blindness, Inc. (FFB). The walk-a-thon is the 2nd annual for Dallas and is the signature fundraiser for Foundation Fighting Blindness, Inc. Over 350 participants joined in...

2009-05-28 07:32:00

LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). RP is a slowly developing condition that causes the progressive degeneration of rod & cone photoreceptor cells in the retina that over time diminishes night and peripheral vision and eventually leads to blindness. RP is an orphan-designated indication for which...

2009-05-22 10:38:02

Stem cells taken from bone marrow show promise in healing damaged retinal tissue, said researchers at the University of Louisville in Kentucky. The stem cells generated new cells in damaged retinal pigment epithelium, the pigmented cell layer just outside the retina, research led by Dr. Suzanne Ildstad showed. The research could lead to healing vision loss and blindness from age-related macular degeneration and hereditary retinal degeneration, she said. The study is be expanded at the Swine...

2009-05-11 07:39:13

The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease "“ the features or disorders associated with it "“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why. In this week's journal Nature Genetics, an international consortium of researchers, including some from Baylor College of Medicine, provide not only an explanation for the variations of vision loss in...

2009-04-29 19:55:00

WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research. Among VA's research projects in the exciting domain of vision restoration for Veterans are the development of an artificial retina to restore vision to those affected by macular degeneration and retinitis pigmentosa; the design and improvement of assistive devices for those with visual impairments; and the development of more accurate and efficient methods of vision testing. To view the Multimedia News...

2009-04-20 12:08:34

Omega three fatty acids protect brain cells by preventing the misfolding of a protein from a gene mutation in Parkinson's disease, U.S. researchers said. Dr. Nicolas Bazan of Louisiana State University and colleagues developed a cell model with a mutation of the Ataxin-1 gene. The defective Ataxin-1 gene induced the misfolding of the protein produced by the gene. The misshapened proteins cannot be properly processed by the cell machinery, resulting in tangled clumps of toxic protein that...

2009-04-19 13:19:27

 Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present new research findings showing that an omega three fatty acid in the diet protects brain cells by preventing the misfolding of a protein resulting from a gene mutation in neurodegenerative diseases like Parkinson's and Huntington's. He will present these findings...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related